Wall St Price Targets

TLT Price Forecast
Based on 3 analysts

+286% Upside
from CA$0.185 today

Theralase Technologies Inc (TLT)’s 12-month stock price forecast through November 2027 has a consensus target of CA$0.714, implying 286% upside. The forecast is based on price targets from 3 Wall Street analysts.

TLT Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for TLT yet.

Theralase Technologies Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TLT's stock price target?
Price Target
0.714 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.714 CAD with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.

What is the Revenue forecast for Theralase Technologies Inc?
Projected CAGR
355%

Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 355%.

What is the Gross Profit forecast for Theralase Technologies Inc?
Projected CAGR
338%

Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 338%.

Back to Top